Head of Hong Kong’s new drug regulator pledges to build trust, push innovation
新聞摘要
以下為來源提供的節錄，完整報道請查看原文。
The head of Hong Kong’s new drug regulatory body has pledged to build a fully capable and globally trusted agency that will become a catalyst for medical innovation rather than merely acting as a “miniature version” of existing overseas models.